Literature DB >> 10557328

Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis.

K A Munger1, A Montero, M Fukunaga, S Uda, T Yura, E Imai, Y Kaneda, J M Valdivielso, K F Badr.   

Abstract

The human 15-lipoxygenase (15-LO) gene was transfected into rat kidneys in vivo via intra-renal arterial injection. Three days later, acute (passive) or accelerated forms of antiglomerular basement membrane antibody-mediated glomerulonephritis were induced in transfected and nontransfected or sham-transfected controls. Studies of glomerular functions (filtration and protein excretion) and ex vivo glomerular leukotriene B(4) biosynthesis at 3 hr, and up to 4 days, after induction of nephritis revealed preservation or normalization of these parameters in transfected kidneys that expressed human 15-LO mRNA and mature protein, but not in contralateral control kidneys or sham-transfected animals. The results provide in vivo-derived data supporting a direct anti-inflammatory role for 15-LO during immune-mediated tissue injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10557328      PMCID: PMC23955          DOI: 10.1073/pnas.96.23.13375

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

Review 1.  Gene transfer into the kidney: promise for unravelling disease mechanisms, limitations for human gene therapy.

Authors:  L G Fine
Journal:  Kidney Int       Date:  1996-03       Impact factor: 10.612

Review 2.  Molecular biological intervention.

Authors:  Y Isaka; E Imai
Journal:  Semin Nephrol       Date:  1996-11       Impact factor: 5.299

3.  Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids.

Authors:  M E Brezinski; C N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

4.  Production of arachidonic acid metabolites by macrophages exposed in vitro to asbestos, carbonyl iron particles, or calcium ionophore.

Authors:  S Kouzan; A R Brody; P Nettesheim; T Eling
Journal:  Am Rev Respir Dis       Date:  1985-04

5.  Leukotrienes stimulate neutrophil adhesion to mesangial cells: modulation with lipoxins.

Authors:  H R Brady; U Persson; B J Ballermann; B M Brenner; C N Serhan
Journal:  Am J Physiol       Date:  1990-11

6.  Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis.

Authors:  Y Akagi; Y Isaka; M Arai; T Kaneko; M Takenaka; T Moriyama; Y Kaneda; A Ando; Y Orita; T Kamada; N Ueda; E Imai
Journal:  Kidney Int       Date:  1996-07       Impact factor: 10.612

7.  The action of lipoxin-A on glomerular microcirculatory dynamics in the rat.

Authors:  K F Badr; C N Serhan; K C Nicolaou; B Samuelsson
Journal:  Biochem Biophys Res Commun       Date:  1987-05-29       Impact factor: 3.575

8.  15-Hydroxyeicosatetraenoic acid inhibits neutrophil migration across cytokine-activated endothelium.

Authors:  S Takata; A Papayianni; M Matsubara; W Jimenez; P H Pronovost; H R Brady
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

Review 9.  Leukotrienes and 15-lipoxygenase products in glomerulonephritis.

Authors:  K F Badr
Journal:  Adv Nephrol Necker Hosp       Date:  1995

10.  Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins.

Authors:  B D Levy; M Romano; H A Chapman; J J Reilly; J Drazen; C N Serhan
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more
  35 in total

Review 1.  15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?

Authors:  Sun Il Lee; Xiangsheng Zuo; Imad Shureiqi
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 2.  Functional and pathological roles of the 12- and 15-lipoxygenases.

Authors:  Anca D Dobrian; David C Lieb; Banumathi K Cole; David A Taylor-Fishwick; Swarup K Chakrabarti; Jerry L Nadler
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

Review 3.  ALOX15 as a suppressor of inflammation and cancer: Lost in the link.

Authors:  Rui Tian; Xiangsheng Zuo; Jonathan Jaoude; Fei Mao; Jennifer Colby; Imad Shureiqi
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-01-13       Impact factor: 3.072

4.  Diminished lipoxin biosynthesis in severe asthma.

Authors:  Bruce D Levy; Caroline Bonnans; Eric S Silverman; Lyle J Palmer; Gautham Marigowda; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2005-06-16       Impact factor: 21.405

Review 5.  Anti-inflammatory and proresolving lipid mediators.

Authors:  Charles N Serhan; Stephanie Yacoubian; Rong Yang
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

6.  Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury.

Authors:  Alexander J Leedom; Aaron B Sullivan; Baiyan Dong; Denise Lau; Karsten Gronert
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

7.  Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes.

Authors:  Hang Yuan; Linda Lanting; Zhong-Gao Xu; Shu-Lian Li; Piotr Swiderski; Sumanth Putta; Mahesh Jonnalagadda; Mitsuo Kato; Rama Natarajan
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-18

Review 8.  A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution.

Authors:  Charles N Serhan
Journal:  Histochem Cell Biol       Date:  2004-08-21       Impact factor: 4.304

Review 9.  Gene therapy for renal disorders: what are the benefits for the elderly?

Authors:  Yeong-Hau H Lien; Li-Wen Lai
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 10.  Lipoxins: resolutionary road.

Authors:  Paola Maderna; Catherine Godson
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.